Search Results

You are looking at 91 - 100 of 125 items for :

  • All content x
Clear All
Orvosi Hetilap
Authors: Tamás Schneider, Erika Tóth, József Lővey, Zsuzsanna Molnár, Beáta Deák, Erika Várady, Judit Csomor, András Matolcsy, Zsolt Lengyel, Klára Petri, István Gaudi, and András Rosta

retrospective study. Clin. Lymphoma Myeloma, 2009, 9 , 381–385. Finolezzi E. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a

Open access

., Li, L., Kottke Marchant, K. et al.: The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma. Mayo Clin. Proc., 2005, 80 , 1549

Restricted access

., Li, L., Kottke Marchant, K. és mtsai: The role of aspirin in the prevention of thrombotic complications of thalidomide and antracycline-based chemotherapy for multiple myeloma. Mayo Clin. Proc., 2005, 80 , 1549

Restricted access
Orvosi Hetilap
Authors: Miklós Szendrői, János Kiss, Tamás Perlaky, Imre Antal, Krisztián Szalay, and Attila Szendrői

metastatic disease. European Instructional Lectures 2012; 12: 35–44. 35 Alvi HM, Damron TA. Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to

Open access
Orvosi Hetilap
Authors: Árpád Bátai, Péter Reményi, Marienn Réti, Anikó Barta, László Gopcsa, Lilla Lengyel, Éva Torbágyi, Zoltán Csukly, Éva Karászi, Attila Tordai, Hajnalka Andrikovics, Katalin Balassa, Szabolcs Tasnády, and Tamás Masszi

multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report. Transplant. Proc., 2013, 45 (10), 3705–3707. 15 Bensinger, W. I

Open access

–1552. 29 Garfall AL, Stadtmauer EA, Hwang WT, et al. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI Insight 2018; 3

Open access
Acta Alimentaria
Authors: L. Hajas, K. A. Scherf, Zs. Bugyi, K. Török, E. Schall, P. Köhler, and S. Tömösközi

disease and in patients with multiple myeloma . BMC Immunol. , 10 , 32 . Mena , M.C. , Lombardía , M. , Hernando , A. , Méndez , E. & Albar

Open access

: implications for multiple myeloma. Eur J Immunol. 2011; 41: 437–449. 21 Jones S, Howl J. Biological applications of the receptor mimetic peptide mastoparan. Curr Protein Pept Sci. 2006; 7

Open access
Hematológia–Transzfuziológia
Authors: Bálint Gergely Szabó, Ilona Bobek, Marienn Réti, László Gopcsa, Dóra Mathiász, Botond Lakatos, Gabriella Bekő, Mónika Pető, János Sinkó, Gábor Mikala, Zoltán Kis, János Szlávik, Péter Reményi, and István Vályi-Nagy

malignant diseases. Leukemia. 2020. [epub, accessed: May 25, 2020] 73 Al Saleh AS, Sher T, Gertz MA. Multiple Myeloma in the Time of COVID-19. Acta

Open access
Orvosi Hetilap
Authors: Árpád Illés, Zsófia Simon, Miklós Udvardy, Ferenc Magyari, Ádám Jóna, and Zsófia Miltényi

patients with relapsed-refractory Hodgkin’s lymphoma with incomplete response before autologous stem cell transplantation. Clin Lymphoma Myeloma Leuk. 2017; 17: 14–22. 26 Poen JC

Restricted access